Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
14,99 NOK | -1,64% | +1,97% | -29,95% |
Omzet 2023 | 141 mln. 12,98 mln. 12,03 mln. | Omzet 2024 * | 157 mln. 14,45 mln. 13,39 mln. | Marktkapitalisatie | 4,89 mld. 450 mln. 418 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -372 mln. -34,23 mln. -31,73 mln. | Nettowinst (verlies) 2024 * | -613 mln. -56,4 mln. -52,29 mln. | EV/omzet 2023 | 49,5 x |
Nettoliquiditeiten 2023 * | 1,84 mld. 169 mln. 157 mln. | Nettoliquiditeiten 2024 * | 1,25 mld. 115 mln. 107 mln. | EV/omzet 2024 * | 23,2 x |
K/w-verhouding 2023 |
-16,8
x | K/w-verhouding 2024 * |
-8,05
x | Werknemers | 334 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 52,34% |
Recentste transcriptie over Nykode Therapeutics
1 dag | -1,64% | ||
1 week | +1,97% | ||
Lopende maand | -9,75% | ||
1 maand | -11,51% | ||
3 maanden | -28,48% | ||
6 maanden | -36,21% | ||
Lopend jaar | -29,95% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 47 | 01-01-07 | |
Michael Engsig
CEO | Chief Executive Officer | - | 01-03-07 |
Harald Gurvin
DFI | Director of Finance/CFO | 49 | 03-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | - |
Director/Board Member | 64 | - | |
Director/Board Member | - | - |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 735 M€ | -.--% | - | |
0.00% | 10 M€ | -3,35% | - | |
0.00% | 150 M€ | -1,65% | - | |
0.00% | 26 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
27-03-24 | 14,99 | -1,64% | 476 595 |
26-03-24 | 15,24 | +4,67% | 866 720 |
25-03-24 | 14,56 | -2,35% | 821 613 |
22-03-24 | 14,91 | +1,43% | 818 250 |
21-03-24 | 14,7 | +1,66% | 2 218 006 |
Real Time Oslo Bors, 27 maart 2024 om 14:20 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-29,95% | 452 mln. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |